Cyxtera Announces First Quarter 2022 Results
Cyxtera (NASDAQ: CYXT) reported Q1 2022 financial results, showcasing a total revenue increase of $9.5 million (5.5% year-over-year) to $182.4 million. Recurring revenue hit $173.7 million, with core revenue rising to $165.9 million. The net loss was $40.9 million, but Transaction Adjusted EBITDA grew by $2.5 million (4.5%) to $58.6 million. The company maintains a stable average monthly core churn of 1.0% and a 70.5% occupancy rate. Cyxtera reaffirmed its 2022 guidance, projecting revenue between $730 million and $760 million, along with plans for expansion in India through a partnership with Sify Technologies.
- Revenue increased by $9.5 million (5.5%) YoY, totaling $182.4 million.
- Recurring revenue increased by $9.0 million (5.5%) YoY to $173.7 million.
- Core revenue rose by $9.7 million (6.2%) YoY to $165.9 million.
- Transaction Adjusted EBITDA improved by $2.5 million (4.5%) YoY to $58.6 million.
- Occupancy rate increased to 70.5%, up 320 basis points YoY.
- Net financial leverage decreased from 5.6x to 3.6x YoY.
- Partnership with Sify Technologies to enter the Indian market.
- Net loss of $40.9 million reported for Q1 2022.
“As we launch into our second year as a publicly traded company, we’re excited to report another strong quarter of results to start 2022,” said
Q1 2022 Financial Highlights
-
Total revenue increased by
, or$9.5 million 5.5% year over year, to in the first quarter.$182.4 million -
Recurring revenue increased by
, or$9.0 million 5.5% year over year, to in the first quarter.$173.7 million -
Core revenue increased by
, or$9.7 million 6.2% year over year, to in the first quarter.$165.9 million -
Net Loss of
in the quarter; Transaction Adjusted EBITDA[1] increased by$40.9 million , or$2.5 million 4.5% year over year, to in the first quarter, principally due to higher revenue partially offset by higher SG&A.$58.6 million
Business Highlights
-
Average monthly Core churn of
1.0% in the first quarter remained flat with the same quarter of last year. -
Stabilized occupancy of
70.5% at first quarter-end 2022, an increase of 320 basis points from Q1 2021. - Continued to de-lever the balance sheet with Q1 2022 net financial leverage of 3.6x, a decrease from 5.6x as of Q1 2021.
-
Signed partnership agreement with
Sify Technologies to enter Indian market and support our customers’ expansion needs. - Joined the iMasons Climate Accord as we continue our ESG journey.
“We are pleased with our team’s high-level execution of Cyxtera’s plan in this environment, which resulted in another strong quarter for the company and gives us confidence to reaffirm guidance for the year,” said
2022 Outlook
2022 Guidance |
|||
($ in millions) |
|
|
|
|
2021 Results |
2022 Guidance |
Y/Y % Change |
Revenue |
|
|
|
Transaction Adjusted EBITDA |
|
|
|
Maintenance Capital Expenditures |
|
|
|
% of Revenue |
|
|
60 bps - 70 bps |
Expansion Capital Expenditures |
|
|
|
Q1 2022 Results Conference Call and Replay Information
The
Investor Presentation and Supplemental Financial Information
Concurrently with holding its conference call,
__________________________________ |
1 A complete reconciliation of Net Loss to Transaction Adjusted EBITDA is included in the financial tables included in this release. |
Upcoming Conferences and Events
- Nareit REITWeek 2022 Investor Conference
-
KeyBanc Technology Leadership Forum - Cowen 8th Annual Communications Infrastructure Summit
About
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the federal securities laws. Forward- looking statements contained in this press release include statements concerning Cyxtera’s estimated financial performance for 2022. Because forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Cyxtera’s control. Actual results and conditions (financial or otherwise) may differ materially from those indicated in the forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results and conditions to differ materially from those indicated in the forward-looking statements, including, but not limited to, the effects of the COVID-19 pandemic on Cyxtera’s business or future results, including supply chain disruptions; increases in interest rates; fluctuations in energy prices; fluctuations in foreign currency exchange rates in the markets in which
Statement Regarding Non-GAAP Financial Measures
This press release contains Transaction Adjusted EBITDA, which is a supplemental measure that is not required by, or presented in accordance with, accounting principles generally accepted in
This press release also includes certain projections of non-GAAP financial measures concerning
Consolidated Balance Sheets (unaudited, in millions, except share information)
|
|||||||
|
|
|
|
||||
Assets: |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash |
$ |
60.1 |
|
|
$ |
52.4 |
|
Accounts receivable, net of allowance of |
|
27.7 |
|
|
|
18.3 |
|
Prepaid and other current assets |
|
35.1 |
|
|
|
37.5 |
|
Total current assets |
|
122.9 |
|
|
|
108.2 |
|
|
|
|
|
||||
Property and equipment, net |
|
1,663.5 |
|
|
|
1,530.8 |
|
Operating lease right-of-use assets |
|
280.3 |
|
|
|
— |
|
|
|
760.5 |
|
|
|
761.7 |
|
Intangible assets, net |
|
472.0 |
|
|
|
519.8 |
|
Other assets |
|
16.9 |
|
|
|
16.7 |
|
Total assets |
$ |
3,316.1 |
|
|
$ |
2,937.2 |
|
|
|
|
|
||||
Liabilities and shareholders’ equity: |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
60.2 |
|
|
$ |
57.9 |
|
Accrued expenses |
|
64.1 |
|
|
|
65.3 |
|
Current portion of operating lease liabilities |
|
32.4 |
|
|
|
— |
|
Current portion of long-term debt, finance leases and other financing obligations |
|
51.0 |
|
|
|
50.3 |
|
Deferred revenue |
|
62.3 |
|
|
|
60.7 |
|
Other current liabilities |
|
9.2 |
|
|
|
10.0 |
|
Total current liabilities |
|
279.2 |
|
|
|
244.2 |
|
|
|
|
|
||||
Operating leases, net of current portion |
|
308.6 |
|
|
|
— |
|
Long-term debt, net of current portion |
|
857.8 |
|
|
|
896.5 |
|
Finance leases and other financing obligations, net of current portion |
|
1,075.8 |
|
|
|
937.8 |
|
Deferred income taxes |
|
33.9 |
|
|
|
29.9 |
|
Warrant liabilities |
|
— |
|
|
|
64.7 |
|
Other liabilities |
|
67.2 |
|
|
|
158.2 |
|
Total liabilities |
|
2,622.5 |
|
|
|
2,331.3 |
|
|
|
|
|
||||
Shareholders’ equity: |
|
|
|
||||
Preferred Stock, |
|
— |
|
|
|
— |
|
Class A common stock, |
|
— |
|
|
|
— |
|
Additional paid-in capital |
|
1,949.1 |
|
|
|
1,816.5 |
|
Accumulated other comprehensive income |
|
6.8 |
|
|
|
10.8 |
|
Accumulated deficit |
|
(1,262.3 |
) |
|
|
(1,221.4 |
) |
Total shareholders’ equity |
|
693.6 |
|
|
|
605.9 |
|
Total liabilities and shareholders’ equity |
$ |
3,316.1 |
|
|
$ |
2,937.2 |
|
Consolidated Statements of Operations (unaudited, in millions, except for share information)
|
|||||||
|
Three Months Ended |
||||||
|
2022 |
|
2021 |
||||
Revenues |
$ |
182.4 |
|
|
$ |
172.9 |
|
Operating costs and expenses |
|
|
|
||||
Cost of revenues, excluding depreciation and amortization |
|
98.0 |
|
|
|
98.4 |
|
Selling, general and administrative expenses |
|
31.3 |
|
|
|
27.6 |
|
Depreciation and amortization |
|
62.3 |
|
|
|
60.6 |
|
Restructuring, impairment, site closures and related costs |
|
1.3 |
|
|
|
8.1 |
|
Total operating costs and expenses |
|
192.9 |
|
|
|
194.7 |
|
|
|
|
|
||||
Loss from operations |
|
(10.5 |
) |
|
|
(21.8 |
) |
Interest expense, net |
|
(38.6 |
) |
|
|
(43.2 |
) |
Other income (expenses), net |
|
0.5 |
|
|
|
(0.5 |
) |
Change in fair value of warrant liabilities |
|
11.8 |
|
|
|
— |
|
Loss from operations before income taxes |
|
(36.8 |
) |
|
|
(65.5 |
) |
Income tax (expense) benefit |
|
(4.1 |
) |
|
|
12.9 |
|
Net loss |
$ |
(40.9 |
) |
|
$ |
(52.6 |
) |
|
|
|
|
||||
Loss Per Share |
|
|
|
||||
Basic and diluted |
$ |
(0.23 |
) |
|
$ |
(0.47 |
) |
|
|
|
|
||||
Weighted average number of shares outstanding |
|
|
|
||||
Basic and diluted |
|
175,182,160 |
|
|
|
111,351,414 |
|
Consolidated Statements of Cash Flows (unaudited, in millions)
|
|||||||
|
Three Months Ended |
||||||
|
2022 |
|
2021 |
||||
Net loss |
$ |
(40.9 |
) |
|
$ |
(52.6 |
) |
Cash flows from operating activities: |
|
|
|
||||
Adjustments to reconcile net loss to net cash provided by operating activities: |
|
|
|
||||
Depreciation and amortization |
|
62.3 |
|
|
|
60.6 |
|
Restructuring, impairment, site closures and related costs |
|
— |
|
|
|
2.0 |
|
Amortization of favorable/unfavorable leasehold interests, net |
|
— |
|
|
|
1.1 |
|
Amortization of debt issuance costs and fees, net |
|
1.0 |
|
|
|
1.4 |
|
Equity-based compensation |
|
3.4 |
|
|
|
1.9 |
|
Reversal of doubtful accounts |
|
(0.3 |
) |
|
|
(0.2 |
) |
Deferred income taxes |
|
4.1 |
|
|
|
(12.9 |
) |
Change of fair value of warrant liabilities |
|
(11.8 |
) |
|
|
— |
|
Non-cash interest expense, net |
|
3.0 |
|
|
|
2.4 |
|
Changes in operating assets and liabilities, excluding impact of acquisitions and dispositions: |
|
|
|
||||
Accounts receivable |
|
(9.0 |
) |
|
|
21.0 |
|
Prepaid and other current assets |
|
2.3 |
|
|
|
2.8 |
|
Other assets |
|
(0.3 |
) |
|
|
(0.5 |
) |
Operating lease right-of-use assets |
|
10.2 |
|
|
|
— |
|
Operating lease liabilities |
|
(10.2 |
) |
|
|
— |
|
Accounts payable |
|
(0.4 |
) |
|
|
(3.1 |
) |
Accrued expenses |
|
(1.2 |
) |
|
|
2.6 |
|
Due to affiliates |
|
— |
|
|
|
(22.7 |
) |
Other liabilities |
|
— |
|
|
|
4.3 |
|
Net cash provided by operating activities |
|
12.2 |
|
|
|
8.1 |
|
Cash flows from investing activities: |
|
|
|
||||
Purchases of property and equipment |
|
(32.4 |
) |
|
|
(13.7 |
) |
Amounts received from affiliate |
|
— |
|
|
|
117.1 |
|
Net cash (used in) provided by investing activities |
|
(32.4 |
) |
|
|
103.4 |
|
Cash flows from financing activities: |
|
|
|
||||
Repayment of long-term debt |
|
(42.3 |
) |
|
|
(2.3 |
) |
Repayment of finance leases and other financing obligations |
|
(11.7 |
) |
|
|
(17.1 |
) |
Proceeds from sales leaseback financing |
|
10.0 |
|
|
|
— |
|
Capital redemption |
|
— |
|
|
|
(97.9 |
) |
Proceeds from the exercise of warrants, net of redemptions |
|
1.3 |
|
|
|
— |
|
Proceeds from the exercise of the optional share purchase options |
|
75.0 |
|
|
|
— |
|
Net cash provided by (used in) financing activities |
|
32.3 |
|
|
|
(117.3 |
) |
Effect of foreign currency exchange rates on cash |
|
(4.4 |
) |
|
|
(1.3 |
) |
Net increase (decrease) in cash |
|
7.7 |
|
|
|
(7.1 |
) |
Cash at beginning of period |
|
52.4 |
|
|
|
120.7 |
|
Cash at end of period |
$ |
60.1 |
|
|
$ |
113.6 |
|
|
|
|
|
||||
Supplemental cash flow information: |
|
|
|
||||
Cash paid for income taxes, net |
$ |
0.7 |
|
|
$ |
0.3 |
|
Cash paid for interest |
$ |
9.6 |
|
|
$ |
25.6 |
|
Non-cash purchases of property and equipment |
$ |
2.8 |
|
|
$ |
9.7 |
|
RECONCILIATION OF GAAP TO NON-GAAP RESULTS (unaudited, in millions)
|
|||||||
|
Three Months Ended |
||||||
|
2022 |
|
2021 |
||||
Net Loss to EBITDA Reconciliation: |
|
|
|
||||
Net loss |
$ |
(40.9 |
) |
|
|
(52.6 |
) |
Depreciation and amortization |
|
62.3 |
|
|
|
60.6 |
|
Interest and other expenses, net |
|
38.1 |
|
|
|
43.7 |
|
Income tax expense (benefit) |
|
4.1 |
|
|
|
(12.9 |
) |
EBITDA |
$ |
63.6 |
|
|
$ |
38.9 |
|
Transaction Adjustments |
|
|
|
||||
Equity-based compensation |
|
3.4 |
|
|
|
1.8 |
|
Straight-line rent adjustment |
|
0.6 |
|
|
|
1.1 |
|
Amortization of Favorable / Unfavorable Leasehold Interest & ARO accretion |
|
0.9 |
|
|
|
0.9 |
|
Stand-up separation & other |
|
0.6 |
|
|
|
3.1 |
|
Restructuring costs & other |
|
1.3 |
|
|
|
10.3 |
|
Change in fair value of warrant liabilities |
|
(11.8 |
) |
|
|
— |
|
Total Adjustments |
|
(5.0 |
) |
|
|
17.2 |
|
Transaction Adjusted EBITDA |
$ |
58.6 |
|
|
$ |
56.1 |
|
|
|
|
|
Note: Numbers may not foot or cross-foot due to rounding
View source version on businesswire.com: https://www.businesswire.com/news/home/20220512005133/en/
Press Contact:
xavier.gonzalez@cyxtera.com
IR Contact:
IR@cyxtera.com
Source:
FAQ
What are Cyxtera's Q1 2022 revenue results?
What is Cyxtera's net loss for Q1 2022?
How did Transaction Adjusted EBITDA change in Q1 2022 for CYXT?
What are the 2022 revenue projections for Cyxtera?